{
  "nctId": "NCT07182617",
  "briefTitle": "MonitAir Remote Patient Monitoring Versus Standard of Care for CPAP Adherence in Obstructive Sleep Apnea",
  "officialTitle": "Assessing the Utility of a Remote Patient Monitoring Platform for Improving CPAP Adherence for Obstructive Sleep Apnea",
  "protocolDocument": {
    "nctId": "NCT07182617",
    "filename": "Prot_SAP_000.pdf",
    "label": "Study Protocol and Statistical Analysis Plan",
    "date": "2024-02-05",
    "uploadDate": "2025-09-16T08:05",
    "size": 58797,
    "downloadUrl": "https://clinicaltrials.gov/api/v2/studies/NCT07182617/document/Prot_SAP_000.pdf",
    "hasProtocol": true,
    "hasSap": true,
    "hasIcf": false
  },
  "phase": [
    "NA"
  ],
  "studyType": "INTERVENTIONAL",
  "allocation": "RANDOMIZED",
  "interventionModel": "PARALLEL",
  "masking": "NONE",
  "enrollmentInfo": {
    "enrollmentCount": 200,
    "enrollmentType": "ACTUAL"
  },
  "timeline": {
    "startDate": "2024-02-05",
    "completionDate": "2025-04-01",
    "primaryCompletionDate": "2025-04-01",
    "firstSubmitDate": "2025-08-26",
    "firstPostDate": "2025-09-19"
  },
  "eligibilityCriteria": {
    "criteria": "Inclusion Criteria:\n\n* Adults ≥18 years old\n* Access to a smartphone (iOS or Android)\n* Ability to engage in two-way text communication and audiovisual conferencing\n* Home sleep test (HST) or polysomnogram (PSG) performed ≤90 days before randomization\n* Apnea-Hypopnea Index (AHI) ≥5 (using 3% desaturation criteria)\n* Prescribed and willing to initiate CPAP or APAP therapy\n* Receiving a ResMed, Philips, or React CPAP device with a cellular modem\n* CPAP data available to MonitAir and BetterNight\n\nExclusion Criteria:\n\n* Department of Transportation (DOT) drivers\n* Central sleep apnea or Cheyne-Stokes respirations (CSA/CSR) ≥10% of diagnostic study\n* Central or mixed apneas ≥25% of AHI\n* Use of BiPAP, BiPAP ST, ASV, AVAPS, or any other non-invasive ventilation modality\n* Inability or unwillingness to participate in study activities or meet requirements",
    "healthyVolunteers": false,
    "sex": "ALL",
    "minimumAge": "18 Years",
    "stdAges": [
      "ADULT",
      "OLDER_ADULT"
    ]
  },
  "endpoints": {
    "primary": [
      {
        "measure": "CPAP adherence according to Medicare criteria",
        "description": "Percentage of patients meeting Medicare adherence criteria, defined as ≥4 hours of CPAP use per night for ≥70% of nights in a consecutive 30-day period, measured at 30, 60, and 90 days.",
        "timeFrame": "Days 30, 60, and 90 after CPAP initiation"
      }
    ],
    "secondary": [
      {
        "measure": "Patient Satisfaction",
        "description": "Patient satisfaction with therapy measured using a 5-point Likert scale (1 = very dissatisfied; 5 = very satisfied). Higher scores reflect greater satisfaction. Administered via electronic survey.",
        "timeFrame": "Baseline, Day 30, Day 60, and Day 90 after starting CPAP"
      },
      {
        "measure": "Time to CMS-defined adherence",
        "description": "Number of days required for each participant to meet CMS adherence criteria: ≥4 hours/night on ≥70% of nights in a consecutive 30-day period within the first 90 days. Lower values indicate faster adherence achievement.",
        "timeFrame": "Baseline to Day 90 after starting CPAP"
      },
      {
        "measure": "Average nightly CPAP use",
        "description": "Mean CPAP use in hours per night, calculated separately for all days and for days with usage, based on device-recorded data. Higher values indicate greater adherence to therapy.",
        "timeFrame": "Day 30, Day 60, and Day 90 after starting CPAP"
      },
      {
        "measure": "Functional Outcomes of Sleep Questionnaire (FOSQ)",
        "description": "Sleep-related quality of life measured by the FOSQ-10. Total score range: 5 (worst) to 20 (best). Higher scores indicate better functional outcomes related to sleep.",
        "timeFrame": "Baseline, Day 30, Day 60, and Day 90 after starting CPAP"
      },
      {
        "measure": "Pittsburgh Sleep Quality Index (PSQI)",
        "description": "Patient-reported global sleep quality using PSQI. Total score range: 0 to 21. Higher scores indicate worse sleep quality. Administered via electronic survey.",
        "timeFrame": "Baseline, Day 30, Day 60, and Day 90 after starting CPAP"
      },
      {
        "measure": "Epworth Sleepiness Scale (ESS)",
        "description": "Daytime sleepiness measured by the ESS. Total score ranges from 0 to 24, with higher scores indicating greater daytime sleepiness.",
        "timeFrame": "Baseline, Day 30, Day 60, and Day 90 after starting CPAP"
      },
      {
        "measure": "Residual Apnea-Hypopnea Index (AHI)",
        "description": "Mean residual AHI (events/hour) captured from CPAP device while on therapy. AHI reflects apneas and hypopneas per hour of use. Lower values indicate better treatment effectiveness.",
        "timeFrame": "Baseline and Day 90 or at Medicare adherence assessment"
      },
      {
        "measure": "Mask leak",
        "description": "Median mask leak (liters per minute) per participant as recorded by CPAP device. Lower values reflect better mask seal and improved therapy delivery.",
        "timeFrame": "Day 30, Day 60, and Day 90 after starting CPAP"
      },
      {
        "measure": "Mask on/off events",
        "description": "Mean number of times per night the CPAP mask is removed and reapplied, as recorded by the device. Lower values reflect better comfort and sleep continuity.",
        "timeFrame": "Day 30, Day 60, and Day 90 after starting CPAP"
      },
      {
        "measure": "Mask refits",
        "description": "Number of mask refitting events performed per participant during the study, as recorded by clinical staff. Fewer refits may reflect better initial fit and mask comfort.",
        "timeFrame": "Up through Day 90 after starting CPAP"
      },
      {
        "measure": "Study dropout rate",
        "description": "Proportion of participants who withdrew from the study. Reasons for dropout (e.g., discomfort, non-adherence, lost to follow-up) will be recorded and categorized.",
        "timeFrame": "Up through Day 90 after starting CPAP"
      }
    ],
    "other": []
  },
  "complexityMetrics": {
    "eligibilityCriteria": {
      "inclusionCount": 0,
      "exclusionCount": 0,
      "totalCount": 0
    },
    "endpoints": {
      "primaryCount": 1,
      "secondaryCount": 11,
      "otherCount": 0,
      "totalCount": 12
    },
    "studyDesign": {
      "phases": [
        "NA"
      ],
      "isRandomized": true,
      "isMasked": false,
      "interventionModel": "PARALLEL"
    },
    "overallComplexityScore": 75,
    "complexityCategory": "Complex"
  },
  "collectionDate": "2025-09-22T05:06:11.775Z",
  "dataSource": "ClinicalTrials.gov API v2 - Ultimate Complete Collection"
}